Nearly 40 million children missed their measles vaccine dose; health experts in the Biden administration are cautiously optimistic about a new campaign for COVID-19 boosters; about 1 in 7 older adults die within a year of having major surgery, according to a new study.
The CDC and the World Health Organization said a record of nearly 40 million children did not receive their measles vaccine last year. According to The Associated Press, the decline stems from the COVID-19 pandemic. The organizations said measles is “an imminent threat in every region of the world.”
Vaccination and booster rates are lower than they should be but Biden health experts remain cautiously optimistic about a new COVID-19 booster campaign, according to Politico. The White House launched a 6-week campaign to encourage getting the booster shot for the holiday season, as respiratory illnesses like the flu, respiratory syncytial virus (RSV), and COVID-19 are affecting the country. Both Anthony Fauci, MD, the retiring head of the National Institute of Allergy and Infectious Diseases, and Ashish Jha, MD, coordinator of the White House’s COVID-19 response, said they are hopeful that RSV is peaking.
A new study found that 1 in 7 older adults died within a year of having a major surgery, according to KHN, with the highest risk among those with probable dementia, frailty, and having emergency surgeries. Age was also linked with worse outcomes, as patients who were aged 90 years and older were 6 times more likely to die compared with patients aged 65 to 69 years.
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More